» Articles » PMID: 32206947

High-protein Diet and Omega-3 Fatty Acids Improve Redox Status in Olanzapine-treated Rats

Overview
Publisher Springer
Specialty Biochemistry
Date 2020 Mar 25
PMID 32206947
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

The present study aimed to estimate the effects of high-protein diet (PD)-isolated whey protein and omega-3 fatty acids-docosahexaenoic and eicosapentaenoic acid on oxidative parameters of rats treated with Olanzapine (OLZ). Experiments were carried out on 8-week-old Wistar albino male rats (n = 64) weighing 200 ± 20 g. By dietary and pharmacological treatment, all animals were divided into 8 groups: 1. CTRL group; 2. CTRL + OLZ group; 3. CTRL + FA group; 4. CTRL + OLZ + FA group; 5. PD group; 6. PD + OLZ group; 7. PD + FA group; 8. PD + OLZ + FA group. After 6 weeks of pharmacological/diet treatment, all animals were sacrificed to collect blood samples and determine the biomarkers of oxidative stress. The following oxidative stress markers were measured spectrophotometrically: superoxide anion radical (O), hydrogen peroxide (HO), nitric oxide (NO), index of lipid peroxidation measured as TBARS, reduced glutathione, catalase and superoxide dismutase. The study has shown that Olanzapine treatment was associated with increased release of pro-oxidants and diminished activity of anti-oxidant markers. Additional supplementation with PD and FA succeeded in abolishing the negative influence in most of the measured parameters. However, these beneficial impacts were stronger in the case of their separate application, which could be the practical and clinical importance of these results.

Citing Articles

Fatty Acid Profile and Genetic Variants of Proteins Involved in Fatty Acid Metabolism Could Be Considered as Disease Predictor.

Chaaba R, Bouaziz A, Ben Amor A, Mnif W, Hammami M, Mehri S Diagnostics (Basel). 2023; 13(5).

PMID: 36900123 PMC: 10001328. DOI: 10.3390/diagnostics13050979.

References
1.
Faghihi T, Jahed A, Mahmoudi-Gharaei J, Sharifi V, Akhondzadeh S, Ghaeli P . Role of Omega-3 fatty acids in preventing metabolic disturbances in patients on olanzapine plus either sodium valproate or lithium: a randomized double-blind placebo-controlled trial. Daru. 2013; 20(1):43. PMC: 3555734. DOI: 10.1186/2008-2231-20-43. View

2.
Xu F, Fan W, Wang W, Tang W, Yang F, Zhang Y . Effects of omega-3 fatty acids on metabolic syndrome in patients with schizophrenia: a 12-week randomized placebo-controlled trial. Psychopharmacology (Berl). 2018; 236(4):1273-1279. DOI: 10.1007/s00213-018-5136-9. View

3.
Eftekhari A, Azarmi Y, Parvizpur A, Eghbal M . Involvement of oxidative stress and mitochondrial/lysosomal cross-talk in olanzapine cytotoxicity in freshly isolated rat hepatocytes. Xenobiotica. 2015; 46(4):369-78. DOI: 10.3109/00498254.2015.1078522. View

4.
Todorovic N, Tomanovic N, Gass P, Filipovic D . Olanzapine modulation of hepatic oxidative stress and inflammation in socially isolated rats. Eur J Pharm Sci. 2015; 81:94-102. DOI: 10.1016/j.ejps.2015.10.010. View

5.
Yao J, Leonard S, Reddy R . Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients. Schizophr Res. 2000; 42(1):7-17. DOI: 10.1016/s0920-9964(99)00095-x. View